Leonard Greenstein
2023
In 2023, Leonard Greenstein earned a total compensation of $2M as Chief Financial Officer at Tarsus Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $71,552 |
|---|---|
| Option Awards | $893,298 |
| Salary | $202,100 |
| Stock Awards | $411,746 |
| Other | $399,883 |
| Total | $1,978,579 |
Greenstein received $893.3K in option awards, accounting for 45% of the total pay in 2023.
Greenstein also received $71.6K in non-equity incentive plan, $202.1K in salary, $411.7K in stock awards and $399.9K in other compensation.
Rankings
In 2023, Leonard Greenstein's compensation ranked 533rd out of 3,006 executives tracked by ExecPay. In other words, Greenstein earned more than 82.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 533 out of 3,006 | 82nd |
Division Manufacturing | 305 out of 1,650 | 82nd |
Major group Chemicals And Allied Products | 212 out of 918 | 77th |
Industry group Drugs | 209 out of 881 | 76th |
Industry Biological Products, Except Diagnostic Substances | 73 out of 213 | 66th |
Source: SEC filing on April 26, 2024.
Greenstein's colleagues
We found three more compensation records of executives who worked with Leonard Greenstein at Tarsus Pharmaceuticals in 2023.